Wanjuan Feng
- Oncology top 10%
- PARP inhibition in cancer therapy 6
- Cancer-related Molecular Pathways 5
- Molecular Biology top 10%
- DNA Repair Mechanisms 14
- CRISPR and Genetic Engineering 5
- Genomics and Chromatin Dynamics 2
- Cancer therapeutics and mechanisms 1
- Porphyrin Metabolism and Disorders 1
-
- Microtubule and mitosis dynamics 3
- Co-authors
- Gaorav P. GuptaDale A. RamsdenRichard D. WoodSteven A. RobertsDavid W. WyattPiotr A. MieczkowskiMichael P. ConlinMatthew J. Yousefzadeh
- Cited by
- OncologyMolecular BiologyAging
- Partner nations
- United StatesHong KongChina
In The Last Decade
Wanjuan Feng
15 papers receiving 873 citations
Peers
Comparison fields: 5 of 52
- Oncology 343
- Molecular Biology 802
- Aging 15
- Cancer Research 93
- Electrochemistry 26
Countries citing papers authored by Wanjuan Feng
This map shows the geographic impact of Wanjuan Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanjuan Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanjuan Feng more than expected).
Fields of papers citing papers by Wanjuan Feng
This network shows the impact of papers produced by Wanjuan Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanjuan Feng. The network helps show where Wanjuan Feng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wanjuan Feng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 18 | |
| 2 | 2023 | 12 | |
| 3 | 2022 | 39 | |
| 4 | 2021 | 21 | |
| 5 | 2021 | 14 | |
| 6 | 2020 | 24 | |
| 7 | 2020 | 105 | |
| 8 | 2020 | 33 | |
| 9 | 2019 | 110 | |
| 10 | 2018 | 73 | |
| 11 | 2016 | 223 | |
| 12 | 2016 | 36 | |
| 13 | 2015 | 21 | |
| 14 | 2012 | 64 | |
| 15 | 2007 | 82 |
About Wanjuan Feng
Wanjuan Feng is a scholar working on Oncology, Molecular Biology and Cell Biology, having authored 15 papers that have together received 875 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (14 papers), PARP inhibition in cancer therapy (6 papers), CRISPR and Genetic Engineering (5 papers), Cancer-related Molecular Pathways (5 papers), Microtubule and mitosis dynamics (3 papers), Genomics and Chromatin Dynamics (2 papers), Cancer therapeutics and mechanisms (1 paper) and Porphyrin Metabolism and Disorders (1 paper). The work is most often cited by research in Oncology (343 citations), Molecular Biology (802 citations) and Aging (15 citations). Wanjuan Feng has collaborated with scholars based in United States, Hong Kong and China. Frequent co-authors include Gaorav P. Gupta, Dale A. Ramsden, Richard D. Wood, Steven A. Roberts, David W. Wyatt, Piotr A. Mieczkowski, Michael P. Conlin, Matthew J. Yousefzadeh, Juan Carvajal-Garcia and Michael S.Y. Huen.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.